Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 3

1(14.3%)

Early Phase 1

1(14.3%)

Phase 1

1(14.3%)

7Total

N/A(4)

Phase 3(1)

Early Phase 1(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04379999Early Phase 1Completed

Atorvastatin ± Aspirin in Lynch Syndrome Syndrome

Role: collaborator

NCT04969341Completed

Improving Lung Cancer Screening Adherence by Overcoming Barriers for Vulnerable Populations

Role: collaborator

NCT05200585Not ApplicableCompleted

Pilot of Lifestyle Behavior Intervention for Non-Alcoholic Fatty Liver Disease

Role: collaborator

NCT04922697Not ApplicableCompleted

Educational Intervention for the Promotion of Knowledge and Preventive Health Behaviors Related to Personal Air Pollution Exposure, The Air Study

Role: collaborator

NCT03340532Not ApplicableCompleted

HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos

Role: collaborator

NCT00976339Phase 1Completed

Study of Vitamin D for Premenopausal Women at High Risk for Breast Cancer

Role: collaborator

NCT02267096Phase 3Completed

Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening

Role: collaborator

NCT00670904Not ApplicableCompleted

Randomized Trial Assessing the Effectiveness of a Pharmacist-Delivered Program for Smoking Cessation

Role: collaborator

All 8 trials loaded